Robinson investigates how care models influence incretin therapy outcomes
Incretin-based therapies, such as GLP-1s and GIPs, have transformed treatment for people with Type II Diabetes (T2D) and obesity. In turn, many clinicians have harnessed…
Weight Management Clinic
-
-
GLP-1 pilot program receives 97% patient approval rating at half-year mark
There is no one-size-fits-all approach to weight management, but recent advancements in GLP-1 based medications offer a new treatment opportunity for patients with obesity and…
